Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc expected to post earnings of $2.14 a share - Earnings Preview

* Chimerix Inc  CMRX.OQ   CMRX.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 3. 
    * The Durham North Carolina-based  company is expected to
report 
a 204,915.9% increase in revenue to $219.367 million from $107
thousand a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Chimerix Inc is for
earnings of $2.14 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Chimerix
Inc is
$6.5​, above​ its last closing price of $1.77. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.25       -0.24      -0.27     Missed  -11.6
 Mar. 31 2022  -0.33       -0.33      -0.28     Beat    15.6
 Dec. 31 2021  -0.32       -0.17      -0.45     Missed  -157.1
                                                        ​
 Sep. 30 2021  -0.14       -0.15      -0.21     Missed  -40.6
 ​​Jun.        -0.19       -0.19      -0.21     Missed  -11.5
 30 2021                                                
 Mar. 31 2021  -0.27       -0.41      -1.21     Missed  -192.3
                                                        ​
 Dec. 31 2020  -0.20       -0.20      -0.19     Beat    3.1
 Sep. 30 2020  -0.17       -0.17      -0.18     Missed  -5.9
 This summary was machine generated November 1 at 11:38 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Chimerix

See all news